| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.007 |